Integrating multi‐omics features enables non‐invasive early diagnosis and treatment response prediction of diffuse large B‐cell lymphoma

A comprehensive multi-omics solution to specifically obtain an extensive fragmentomics landscape, presented by breakpoint characteristics of nucleosomes, CpG islands, DNase clusters and enhancers, besides typical methylation, copy number alteration of cfDNA. Integrated model of cfDNA multi-omics could be used for non-invasive early diagnosis of DLBCL. Integrated model of cfDNA multi-omics could effectively evaluate the efficacy of R-CHOP before DLBCL treatment.

Authors

Institutions

Publication Details

Journal
Clinical and Translational Medicine
Published
2025-01-01
DOI
https://doi.org/10.1002/ctm2.70174
Citations
6
Primary Topic
Cancer Genomics and Diagnostics
Type
article
Field-Weighted Citation Impact
5.62
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Integrating multi‐omics features enables non‐invasive early diagnosis and treatment response prediction of diffuse large B‐cell lymphoma

Jiahao Lyu, Wenxin Qi, Dan Yuan, Yanzhao Li et al.
6 citations
Clinical and Translational Medicine
Cancer Genomics and Diagnostics
5.62
article

Integrating multi‐omics features enables non‐invasive early diagnosis and treatment response prediction of diffuse large B‐cell lymphoma

Jiahao Lyu, Wenxin Qi, Dan Yuan, Yanzhao Li, Xiaoyu Hao, Wenzhe Si, Yang Song, Hairong Jing, Ping Yang, Hongmei Jing, Yuqi Zhang, Yan Liu, Jing Wang, Yan Li, Xu Zhang, Fan Yang, Zijian Zhao, Lingli Wang, Zhihong Wu, Weilong Zhang, Chaoling Wu, Fei Dong, Kang Peng, Baoying Ye
article en
6 citations

Abstract

A comprehensive multi-omics solution to specifically obtain an extensive fragmentomics landscape, presented by breakpoint characteristics of nucleosomes, CpG islands, DNase clusters and enhancers, besides typical methylation, copy number alteration of cfDNA. Integrated model of cfDNA multi-omics could be used for non-invasive early diagnosis of DLBCL. Integrated model of cfDNA multi-omics could effectively evaluate the efficacy of R-CHOP before DLBCL treatment.

Clinical and Translational MedicineVol. 15(1)
Peking University (CN), BOE Technology Group (China) (CN), Peking University Third Hospital (CN)
Life below water
Openalex Percentile: Top 4%
Cancer Genomics and Diagnostics
5.62
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.